MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professional to detect, monitor and start treating AMD three years before it can be seen in order to prevent vision loss. MacuLogix provides in-practice training and best practices to support the effective and efficient implementation and use of the AdaptDx